Duloxetine versus ‘active’ placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

BACKGROUND: Major depression significantly impairs quality of life, increases the risk of suicide, and poses tremendous economic burden on individuals and societies. Duloxetine, a serotonin norepinephrine reuptake inhibitor, is a widely prescribed antidepressant. The effects of duloxetine have, howe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Syst Rev
Main Authors: Siddiqui, Faiza, Barbateskovic, Marija, Juul, Sophie, Katakam, Kiran Kumar, Munkholm, Klaus, Gluud, Christian, Jakobsen, Janus Christian
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8191126/
https://ncbi.nlm.nih.gov/pubmed/34108032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-021-01722-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki